PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2011 2012 2013 2014
The American Society for Microbiology (ASM), in coordination with the Centers for Disease Control and Prevention (CDC)-Guyana, the Guyana Ministry of Health (MOH), the National Tuberculosis Programme (NTP), and other local partners, will continue to expand its technical assistance (TA) to the Guyanese public health laboratory network, with emphasis on tuberculosis (TB) and other microbial opportunistic infections (OI). The specific objectives for FY12 are: 1. Continued improve human resources and laboratory infrastructure (including biosafety) for diagnosis of TB at National Public Health Reference Laboratory (NPHRL) and select peripheral laboratories. 2. ASMs TA will continue to concentrate primarily on the NPHRL. However, during the annual visit by the ASM Program Manager, a plan will be developed to expand assistance to other TB laboratories in Guyana, taking into consideration the lessons learned during the previous year at the NPHL. To make better use of the scarce resources allocated to this program, ASM will coordinate its efforts with other partners, such as PAHO, to avoid duplication of activities; and also build on the lessons learned from FY11 activities. ASM will also continue to pull from its multiple in-house programs (fellowships, professorships etc) and resources (books etc) to help build local scientific capacity. ASM will continue to emphasize M&E as a means of routinely tracking the key elements of program performance and proposes to optimize efforts by developing more standardized and harmonized tools for data collection and reporting, which should be aligned with Guyanas existing data collection systems. This would minimize parallel M&E efforts and diminish reporting burden. These activities will be overseen by a staff M&E specialist.
For FY12, the ASM consultant will continue to train National Public Health Reference Laboratory (NPHRL) laboratorians in tuberculosis (TB) solid culture, and newly implement multi-drug resistant TB identification and drug susceptibility testing (DST); and expand this training to other labs in the country. S/he will also assist with the introduction of new diagnostic methods, such as Capillia and line probe assays. ASM consultants will also continue to train NPHRL and regional laboratorians on opportunistic infection (OI) diagnostic techniques indentified as being needed by the national HIV care and treatment program in FY11.
